FinEdge Labs
L

LH

LHUnverified
4 segments tracked|5 years of data|Annual (10-K)
Total Revenue
$13.1B7.2%
FY2024
Operating Segments
4
Active segments
Blended Margin
10.7%
Operating margin
Highest Margin
15.8%
Diagnostics
Segment Shift

Diagnostics has grown from 65.5% to 77.6% of total revenue since FY2020, with 15.8% operating margins.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2024

SegmentRevenueOp. IncomeMargin% of TotalYoY
Diagnostics$10.1B$1.6B15.8%77.6%+7.7%
Biopharma Laboratory Services$2.9B$459M15.7%22.4%+0.0%
Corporate$0$-671M0.0%0.0%+0.0%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free